Eastern Bank’s IDEAYA Biosciences IDYA Stock Holding History

Eastern Bank’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-192	Closed	-$6.4K	–	1113
2026 Q1	$6.4K	Hold	192	–	–	﹤0.01%	907
2025 Q4	$6.64K	Buy	+192	New	+$6.12K	﹤0.01%	931

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eastern Bank's IDYA Position: Q2 2026 in Review

Eastern Bank sold out of IDEAYA Biosciences (IDYA) in Q2 2026, closing a stake of 192 shares — an estimated $6.4K sold.

Eastern Bank first reported a position in IDYA in Q4 2025 and held it in 2 quarters. The position peaked at $6.64K in Q4 2025. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

Eastern Bank reported no remaining IDEAYA Biosciences position as of Q2 2026 after selling out during the quarter.
Eastern Bank sold 192 IDEAYA Biosciences shares in Q2 2026, an estimated $6.4K.
Eastern Bank first reported a position in IDEAYA Biosciences in Q4 2025 and held it in 2 quarters.
Eastern Bank's IDEAYA Biosciences position peaked at $6.64K in Q4 2025.
284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.